Rennes University Hospital: Multiple Sclerosis trials

The registry lists 21 Multiple Sclerosis studies with Rennes University Hospital as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 3 5No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple SclerosisRecruitingNCT06592703Phase 1
• RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.RecruitingNCT05758831Phase 3
• Defining an Immunological Signature Related to Lesion Location in Multiple SclerosisCompletedNCT05326048
• IL-2 Signaling and Polarization of Regulatory LBs: Involvement in Multiple SclerosisCompletedNCT04697407Not applicable
• Investigation of Novel Immunological Biomarkers by Mass Cytometry in Patients With Early Multiple Sclerosis (CISCO)CompletedNCT04510350
• MUltiple Sclerosis : T Cell / B Cell ExplorationCompletedNCT04231253
• Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple SclerosisCompletedNCT04220814Not applicable
• Preventive Use of COrticosteroids During the Post-Partum in Relapsing MS Patients (COPP-MS)CompletedNCT03917589
• B Cell Differentiation in MSCompletedNCT03744351Not applicable
• Validation of a Self-questionnaire in French on the Use of the Upper Limbs in Patients With Multiple SclerosisCompletedNCT03655093
• Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)Active, not recruitingNCT03653273Phase 3
• Clinical Decision Support System (CADIMS) for MS DiagnosticCompletedNCT03205280
• National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple SclerosisCompletedNCT02937285Phase 3
• Urinary Markers of Detrusor Overactivity in Spina Bifida PatientsCompletedNCT02852317
• Impact of Multiple Sclerosis From the Viewpoint of the Patients and Their CaregiversCompletedNCT02388334
• EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis PatientsCompletedNCT02117375Not applicable
• The Inflammatory Process and the Medical Imaging in Patients With an Inflammatory Disease of the Central Nervous System.TerminatedNCT01567553
• Impact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple SclerosisCompletedNCT01065727Not applicable
• Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) RelapsesStatus unknownNCT00984984Phase 3
• Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis PatientsCompletedNCT00280592Phase 3
• Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple SclerosisTerminatedNCT00219908Phase 2